Chicago, IL, United States of America

Julie M Miyashiro


 

 

Average Co-Inventor Count = 6.2

ph-index = 13

Forward Citations = 704(Granted Patents)


Location History:

  • Evanston, IL (US) (1990)
  • Chicago, IL (US) (1988 - 2005)
  • Skokie, IL (US) (1998 - 2005)
  • Morton Grove, IL (US) (2010 - 2017)

Company Filing History:


Years Active: 1988-2017

Loading Chart...
Loading Chart...
Loading Chart...
42 patents (USPTO):

Title: Julie M. Miyashiro: A Pioneer in Kinase Inhibition and Patent Innovation

Introduction

Julie M. Miyashiro is a prominent inventor based in Chicago, IL, recognized for her significant contributions to the field of pharmaceutical sciences. With an impressive portfolio of 41 patents, she has focused her research on developing novel compounds that serve as effective kinase inhibitors, particularly in the treatment of cancer.

Latest Patents

Among her latest innovations, Julie has introduced two noteworthy patents. The first patent details "Pyridine CDK9 kinase inhibitors," which discloses compounds of Formula (Ia) and their pharmaceutically acceptable salts. These compounds are aimed at treating a variety of diseases, including cancer, highlighting their potential therapeutic applications.

The second patent is centered around "5-substituted indazoles as kinase inhibitors." This invention involves compounds of formula (I), along with their pharmaceutical salts. It elaborates on methods for synthesizing these compounds, which have significant utility in inhibiting critical kinases such as Glycogen Synthase Kinase 3 (GSK-3), Rho kinase (ROCK), and Janus Kinases (JAK), among others.

Career Highlights

Throughout her career, Julie M. Miyashiro has worked with renowned companies, including G.D. Searle & Company and AbbVie Inc. Her expertise in drug formulation and development has made her an invaluable asset to these establishments.

Collaborations

Julie has also collaborated with esteemed colleagues in the industry, including Thomas Dale Penning and James W. Malecha. Together, they have contributed to advancing research and innovation within the field of pharmaceuticals, particularly focusing on the improvement of cancer treatment methodologies.

Conclusion

In summary, Julie M. Miyashiro's extensive patent portfolio and her commitment to advancing pharmaceutical sciences position her as a pioneering inventor in the realm of kinase inhibition. Her work continues to hold great promise for the future of cancer treatments and underscores the importance of innovation within the medical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…